ProKidney Corp. (PROK) Stock News & Chart | StockAdder

(PROK)

ProKidney Corp.

Stock chart and latest news for ProKidney Corp., tracked under Pharmaceuticals, Biotechnology & Life Sciences in the Health Care sector.

Chart powered byTradingView— professional charts for every trader.Try it free →

ProKidney Corp. News

PRO

ProKidney (NASDAQ:PROK) Sees Strong Trading Volume - Time to Buy?

Apr 13, 2026 Yahoo Finance

ProKidney Corp. (PROK) Positioned to Redefine Chronic Kidney Disease Treatment, Believes H.C. Wainwright

Dec 27, 2025 Stock Titan

ProKidney hires ex-Shield CEO Greg Madison for rilparencel launch prep

Mar 25, 2026 Forbes

ProKidney: What's Happening With PROK Stock?

Jul 9, 2025 Trefis

What’s Behind The 500% Rise In ProKidney Stock?

Jul 9, 2025 Seeking Alpha

ProKidney Stock: Differentiated CKD Approach Positions Rilparencel Favorably (NASDAQ:PROK)

Jan 31, 2026 Yahoo Finance

What Makes ProKidney Corp. (PROK) So Attractive

Mar 31, 2026 simplywall.st

Individual investors who hold 32% of ProKidney Corp. (NASDAQ:PROK) gained 560%, institutions profited as well

Jul 9, 2025 GlobeNewswire

ProKidney Expands Senior Leadership Team with Appointment of Greg Madison as Chief Commercial Officer

Mar 25, 2026 Investing.com

ProKidney stock soars after positive Phase 2 trial results

Jul 8, 2025 MarketBeat

ProKidney (NASDAQ:PROK) Shares Up 5.9% - Here's Why

Mar 30, 2026 Seeking Alpha

ProKidney: Slow-Burning 'Buy' Opportunity Based On 2027 Approval Of Kidney Disease Therapy